Zwiers E, Montizaan D, Kip A, Waaijenberg K, Fichtinger P, Mathur S
Front Immunol. 2025; 16:1533407.
PMID: 40051617
PMC: 11882434.
DOI: 10.3389/fimmu.2025.1533407.
Maqsood R, Gul S, Malik J, Ali I
Indian J Otolaryngol Head Neck Surg. 2024; 76(6):5542-5548.
PMID: 39559105
PMC: 11569289.
DOI: 10.1007/s12070-024-05026-7.
Bakakos P, Alobid I, Constantinidis J, Hellings P, Pfaar O, Taille C
J Allergy Clin Immunol Glob. 2024; 4(1):100343.
PMID: 39554605
PMC: 11567123.
DOI: 10.1016/j.jacig.2024.100343.
Kim M, Cho S, Lee H, Jung S, Jeong J
J Clin Med. 2024; 13(19).
PMID: 39407908
PMC: 11477001.
DOI: 10.3390/jcm13195849.
Cheon J, Kim B, Lee J, Shin J, Kim T
Int J Mol Sci. 2024; 25(17).
PMID: 39273399
PMC: 11394744.
DOI: 10.3390/ijms25179455.
IL-13 and IL-13-induced periostin levels are specifically decreased in patients following endoscopic sinus surgery for chronic rhinosinusitis.
Harmon R, Schneider A, Bai J, Racette S, Reddy A, Huang J
J Allergy Clin Immunol. 2023; 153(5):1292-1305.
PMID: 38157944
PMC: 11070299.
DOI: 10.1016/j.jaci.2023.11.922.
Macroarray expression analysis of cytokines and prostaglandin metabolism-related genes in chronic rhinosinusitis.
Oka A, Kanai K, Higaki T, Makihara S, Noda Y, Kariya S
J Allergy Clin Immunol Glob. 2023; 2(3):100123.
PMID: 37779524
PMC: 10509877.
DOI: 10.1016/j.jacig.2023.100123.
Involvement of CD40-CD40L and ICOS-ICOSL in the development of chronic rhinosinusitis by targeting eosinophils.
Zhou A, Shi C, Fan Y, Zheng Y, Wang J, Liu Z
Front Immunol. 2023; 14:1171308.
PMID: 37325657
PMC: 10267736.
DOI: 10.3389/fimmu.2023.1171308.
Eosinophilic Airway Diseases: From Pathophysiological Mechanisms to Clinical Practice.
Mormile M, Mormile I, Fuschillo S, Rossi F, Lamagna L, Ambrosino P
Int J Mol Sci. 2023; 24(8).
PMID: 37108417
PMC: 10138384.
DOI: 10.3390/ijms24087254.
Sinonasal Stent Coated with Sustained-Release Varnish of Mometasone Furoate Inhibits Pro-Inflammatory Cytokine Release from Macrophages: An In Vitro Study.
Cataldo Russomando A, Steinberg D, Gati I, Sionov R, Eliashar R, Friedman M
Pharmaceutics. 2023; 15(3).
PMID: 36986875
PMC: 10051169.
DOI: 10.3390/pharmaceutics15031015.
Molecular and Clinical Predictors of Quality of Life in Chronic Rhinosinusitis with Nasal Polyps.
Brunet A, Milara J, Frias S, Cortijo J, Armengot M
J Clin Med. 2023; 12(4).
PMID: 36835929
PMC: 9965377.
DOI: 10.3390/jcm12041391.
[Expression and predictive value of type Ⅱ inflammatory cytokines in nasal secretion in eosinophilic chronic rhinosinusitis with nasal polyps].
Zhang Z, Ma F, Liu J, Xie L, Cao W, Zhang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2022; 36(12):934-939.
PMID: 36543402
PMC: 10128274.
DOI: 10.13201/j.issn.2096-7993.2022.12.009.
Eosinophilic and Non-eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Their Clinical Comparison in Indian Population.
Guthikonda M, Gude A, Nutakki A
Indian J Otolaryngol Head Neck Surg. 2022; 74(Suppl 2):994-1000.
PMID: 36452721
PMC: 9701980.
DOI: 10.1007/s12070-020-02062-x.
Characterization of the Notch pathway in nasal polyps of patients with chronic rhinosinusitis: A pilot study.
Aquila G, Alaimo A, Marracino L, Martino V, Camponogara F, Vieceli Dalla Sega F
Physiol Rep. 2022; 10(16):e15403.
PMID: 36029197
PMC: 9419157.
DOI: 10.14814/phy2.15403.
Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis.
Kokubo K, Onodera A, Kiuchi M, Tsuji K, Hirahara K, Nakayama T
Front Immunol. 2022; 13:945063.
PMID: 36016937
PMC: 9395650.
DOI: 10.3389/fimmu.2022.945063.
Management of Patients with Severe Asthma and Chronic Rhinosinusitis with Nasal Polyps: A Multidisciplinary Shared Approach.
Seccia V, DAmato M, Scioscia G, Bagnasco D, Di Marco F, Fadda G
J Pers Med. 2022; 12(7).
PMID: 35887593
PMC: 9320671.
DOI: 10.3390/jpm12071096.
Chronic Rhinosinusitis, Biofilm and Secreted Products, Inflammatory Responses, and Disease Severity.
Shaghayegh G, Cooksley C, Ramezanpour M, Wormald P, Psaltis A, Vreugde S
Biomedicines. 2022; 10(6).
PMID: 35740385
PMC: 9220248.
DOI: 10.3390/biomedicines10061362.
Persistent discharge or edema after endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with a type 1 or 3 endotype.
Stein E, Schneider A, Harmon R, Racette S, Reddy A, Price C
Int Forum Allergy Rhinol. 2022; 13(1):15-24.
PMID: 35670482
PMC: 9726991.
DOI: 10.1002/alr.23042.
A novel risk score for disease control prediction of chronic rhinosinusitis.
Jiang L, Wang K, Lin T, Jiang Y, Gao W, Li C
Clin Otolaryngol. 2022; 47(5):568-576.
PMID: 35622459
PMC: 9542583.
DOI: 10.1111/coa.13949.
The Role of Proprotein Convertases in Upper Airway Remodeling.
Lee S, Yoon J
Mol Cells. 2022; 45(6):353-361.
PMID: 35611689
PMC: 9200660.
DOI: 10.14348/molcells.2022.0019.